{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:40:32Z","timestamp":1787917232151,"version":"build-2784847793"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Services Research"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To generate evidence regarding the offensive (customer acquisition) versus defensive (customer retention) motivation for pharmaceutical manufacturer coupons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources and Study Setting<\/jats:title><jats:p>Retail prescriptions from IQVIA's Formulary Impact Analyzer data between 2017 and 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design<\/jats:title><jats:p>Ordinary least squares regression models with person, therapeutic class, drug, and time\u2010fixed effects to measure the association between switching medications and coupon usage as well as the association between patient out\u2010of\u2010pocket spending and switching to a drug and using a coupon. To study switching type heterogeneity, reanalysis of associations for any type of switch, generic\u2010brand switches, and brand\u2010brand switches. Reestimation of baseline analyses for sodium\u2010glucose cotransporter\u20102 inhibitors, anticoagulants, and inhaled corticosteroids\/long\u2010acting beta2\u2010agonists to assess heterogeneity by drug class and market maturity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Collection<\/jats:title><jats:p>1,167,132 privately insured patients that utilized at least one coupon between 2017 and 2019 for one or more prescriptions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Principal Findings<\/jats:title><jats:p>Coupon usage was associated with a 1.0 percentage point reduction in any kind of drug switch in the full sample and by 0.65\u20132.9 percentage points for the drug class subgroups. However, these estimates are governed by market dynamics; the probability of switching increased by 40% on the first coupon usage before declining by more than 50% on subsequent coupons. Switching after the first coupon use may be explained by systematic savings implied by coupon use; we find coupons reduced patient out\u2010of\u2010pocket spending by $45.00 (i.e., the majority of patient out\u2010of\u2010pocket costs). In subgroup analyses, coupon savings were $6.43 larger than average for anticoagulants, characterized by the highest levels of brand and generic competition among the considered therapeutic classes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Pharmaceutical manufacturers may be using coupons to acquire customers and then build brand loyalty, especially in markets with more generic competition. Antitrust authorities and other regulators should scrutinize the impact of coupons on market competitiveness and drug spending.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1475-6773.14379","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T06:53:51Z","timestamp":1725260031000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["On the motivation for pharmaceutical manufacturer coupons: Brand loyalty or customer acquisition?"],"prefix":"10.1111","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-6897","authenticated-orcid":false,"given":"Jason Brian","family":"Gibbons","sequence":"first","affiliation":[{"name":"Department of Health Systems Management &amp; Policy, Colorado School of Public Health University of Colorado Anschutz Medical Campus  Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hermosilla","sequence":"additional","affiliation":[{"name":"Carey Business School Johns Hopkins University  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Department of International Health, Bloomberg School of Public Health Johns Hopkins University  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"How Do Prescription Drug Costs in the United States Compare to Other Countries","author":"Nisha K","year":"2022"},{"key":"e_1_2_9_3_1","volume-title":"Public Opinion on Prescription Drugs and Their Prices","author":"Hamel L","year":"2021"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12104"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1906010"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4619"},{"key":"e_1_2_9_7_1","first-page":"1331","article-title":"Reputation and authority: the FDA and the fight over US prescription drug importation","volume":"73","author":"Bollyky TJ","year":"2020","journal-title":"Vand L Rev"},{"key":"e_1_2_9_8_1","volume-title":"Pfizer, Abbot, Glaxo Sued over Brand\u2010Drug Co\u2010Pay Discounts","author":"Milford P","year":"2012"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1377\/hblog20180215.988517"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ptdy.2016.11.023"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1257\/pol.20150588"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3386\/w29735"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijindorg.2020.102611"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.2123"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.3180"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","unstructured":"DafnyL HoK HoK KongE.How do copayment coupons affect branded drug prices and quantities purchased?NBER Working Paper No. w297352022.https:\/\/ssrn.com\/abstract=4034185. doi:10.2139\/ssrn.4034185","DOI":"10.2139\/ssrn.4034185"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1301993"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.2018.3123"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1802"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1287\/mksc.14.4.395"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1509\/jmkr.41.3.281.35986"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-7187(90)90002-I"},{"key":"e_1_2_9_23_1","volume-title":"Available IQVIA Data","author":"The IQVIA Institute","year":"2023"},{"key":"e_1_2_9_24_1","volume-title":"The Uniform System of Classification","author":"Hunkler R","year":"2018"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.2307\/3150402"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.2307\/3151862"}],"container-title":["Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1475-6773.14379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T01:59:57Z","timestamp":1743559197000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1475-6773.14379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/1475-6773.14379"],"URL":"https:\/\/doi.org\/10.1111\/1475-6773.14379","archive":["Portico"],"relation":{},"ISSN":["0017-9124","1475-6773"],"issn-type":[{"value":"0017-9124","type":"print"},{"value":"1475-6773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"2024-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14379"}}